妊娠期肝内胆汁淤积症诊断与管理

doi:10.3969/j.issn.1672-5069.2020.01.042

实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (1): 153-155.doi: 10.3969/j.issn.1672-5069.2020.01.042

妊娠期肝内胆汁淤积症诊断与管理

陈慧婷, 周永健

510180 广州市华南理工大学附属第二医院消化内科

收稿日期:2019-11-17 出版日期:2020-01-10 发布日期:2020-01-14
通讯作者: 周永健,E-mail:eyzhouyongjian@scut.edu.cn

Diagnosis and management of patients with intrahepatic cholestasis of pregnancy

Chen Huiting, Zhou Yongjian

Department of Gastroenterology,Second Affiliated Hospital,Huanan university of science and engineering,Guangzhou 510180,Guangdong Province,China

Received:2019-11-17 Online:2020-01-10 Published:2020-01-14

摘要/Abstract

关键词: 妊娠期肝内胆汁淤积症, 诊断, 管理

Key words: Intrahepatic cholestasis of pregnancy, Diagnosis, Management

陈慧婷, 周永健. 妊娠期肝内胆汁淤积症诊断与管理[J]. 实用肝脏病杂志, 2020, 23(1): 153-155.

Chen Huiting, Zhou Yongjian. Diagnosis and management of patients with intrahepatic cholestasis of pregnancy[J]. Journal of Practical Hepatology, 2020, 23(1): 153-155.

[1] 中华医学会妇产科学分会产科学组.妊娠期肝内胆汁淤积症诊疗指南( 2015).中华妇产科杂志,2015,50( 7):481-485.
[2] Hillman SC, Stokes-Lampard H, Kilby MD. Intrahepatic cholestasis of pregnancy.BMJ,2016,353:1-2.
[3] 中华医学会肝病学分会、消化病学分会、感染病学分会.胆汁淤积性肝病诊断和治疗共识(2015).实用肝脏病杂志,2016,19(6):I-XI.
[4] Royal College of Obstetricians and Gynaecologists.Obstetric cholestasis ( Green-top Guid-eline No.43 ) ,April 2011 [J/OL].RCOG[2011-05-11]https: / /www.rcog.org.uk/globalassets/d-ocuments/guidelines/gtg_43.pdf.
[5] Ozkan S,Ceylan Y,Ozkan OV,et al. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.World J Gastroenterol, 2015,21(23):7134-7141.
[6] Savander M,Ropponen A,Avela K,et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy.Gut,2003,52: 1025-1029.
[7] 葛星,徐叶青.妊娠期肝内胆汁淤积症对分娩结局影响的出生队列研究中华流行病学杂志, 2016,37(2):187-191.
[8] Hardikar W, Kansal S, Oude Elferink RP, et al. Intrahepatic cholestasis of pregnancy: when should you look further? World J Gastroenterol, 2009, 15(9): 1126-1129.
[9] Mazhar SB, Rahim F, Furukh T. Fetomaternal outcome in triplet pregnancy. J Coll Physicians Surg Pak, 2008, 18(4):217-221.
[10] Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses .Lancet, 2019 , 393(10174):899-909.
[11] Chappell LC. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet, 2019,[ahead of print].
[12] Smolarczyk R, Grymowicz M, Sienko J, et al. Successful perinatal outcome in an early onset intrahepatic cholestasis of pregnancy with extremely high serum hepatic function tests. Gynecol Endocrinol, 2009, 25(7): 475-476.
[13] Estiú MC,Frailuna MA,Otero C. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One,2017,12(4):1-15.
[14] Geenes V,Chappell LC,Seed PT. Association of severe intrahepatic cholestasis of pregna-ncy with adverse pregnancy outcomes: a prospective population-based case-control study.Hepatology,2014,59 (4):1482-1491.
[15] Gabzdyl EM,Schlaeger JM. Intrahepatic cholestasis of pregnancy: acritical clinical review. J Perinat Neonat Nurs,2015,1:41-50.
[16] Mozurkewich E, Chilimigras J, Koepke E, et al. Indications for induction of labour: a best-evidence review. BJOG,2009, 116(5): 626-636.

妊娠期肝内胆汁淤积症诊断与管理

Diagnosis and management of patients with intrahepatic cholestasis of pregnancy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨可芷, 陆伟, 黄丹, 李秀芬, 王雁冰, 周新兰, 丁蓉蓉, 张占卿. γ-谷氨酰转肽酶/胆碱酯酶比值预测慢性乙型肝炎患者肝纤维化程度的效能评价^*[J]. 实用肝脏病杂志, 2020, 23(1): 14-17.
[2]	叶细容, 吕志红, 江峰, 解育新. 两种超声弹性成像技术诊断慢性乙型肝炎患者肝纤维化价值比较^*[J]. 实用肝脏病杂志, 2020, 23(1): 18-21.
[3]	陈丽丽, 符茂雄, 蒙绪标, 方其超. 空腹C肽评估NAFLD合并T2DM患者肝纤维化进展价值分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 38-41.
[4]	柳健, 朱峰发, 唐娟. 非均匀性脂肪肝患者腹部超声表现和血脂变化特点^*[J]. 实用肝脏病杂志, 2020, 23(1): 42-45.
[5]	周晓旭, 张华杰, 商志娟. 速度向量成像技术定量参数评估妊娠期肝内胆汁淤积症孕妇胎儿心功能研究^*[J]. 实用肝脏病杂志, 2020, 23(1): 62-65.
[6]	王晶晶, 李春涛, 周卫真. 失代偿期乙型肝炎肝硬化患者尿液视黄醇结合蛋白水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2020, 23(1): 74-77.
[7]	刘潇, 何年安, 叶显俊, 刘力, 付文学, 陈姣姣. 超声造影对肝细胞癌与肝转移癌的鉴别诊断价值分析[J]. 实用肝脏病杂志, 2020, 23(1): 94-97.
[8]	石莹莹, 王元喜. 应用肝脏影像报告与数据管理系统诊断肝细胞癌的价值研究^*[J]. 实用肝脏病杂志, 2020, 23(1): 98-101.
[9]	高莉, 高屹, 尹秋萍. CT灌注成像联合彩色多普勒超声造影辨别肝脏结节性病变性质临床价值探讨^*[J]. 实用肝脏病杂志, 2020, 23(1): 106-109.
[10]	王秀清, 马燕君, 詹晋莉. 微泡性多囊肝影像学检查表现比较^*[J]. 实用肝脏病杂志, 2020, 23(1): 114-117.
[11]	王纯, 陈东风. Fitz-Hugh-Curtis综合征研究进展^*[J]. 实用肝脏病杂志, 2020, 23(1): 149-152.
[12]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[13]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[14]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[15]	汤人夷, 胡群凤, 彭莉晴. 妊娠期肝内胆汁淤积症患者血脂、肝功能和雌激素水平的变化及临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 860-863.